3,4-Methylenedioxy-N-methoxyamphetamine

3,4-Methylenedioxy-N-methoxyamphetamine
Names
	Preferred IUPAC name 1-(2H-1,3-Benzodioxol-5-yl)-N-methoxypropan-2-amine
Identifiers
CAS Number	74698-48-9 ;
3D model (JSmol)	Interactive image;
ChemSpider	21106333 ;
PubChem CID	44719583;
UNII	2N67Z48J84 ;
CompTox Dashboard (EPA)	DTXSID50660370;
	InChI InChI=1S/C11H15NO3/c1-8(12-13-2)5-9-3-4-10-11(6-9)15-7-14-10/h3-4,6,8,12H,5,7H2,1-2H3 Key: MTIKJUJMCMDSGM-UHFFFAOYSA-N ; InChI=1/C11H15NO3/c1-8(12-13-2)5-9-3-4-10-11(6-9)15-7-14-10/h3-4,6,8,12H,5,7H2,1-2H3 Key: MTIKJUJMCMDSGM-UHFFFAOYAV;
	SMILES CC(NOC)Cc1ccc2OCOc2c1;
Properties
Chemical formula	C11H15NO3
Molar mass	209.245 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

3,4-Methylenedioxy-N-methoxyamphetamine (MDMEO, MDMEOA, or MDMeOA) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxy analogue of MDA. MDMEO was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg. MDMEO may be found as white crystals. It produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEO.